FDA Inspection
Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding PharmacyKelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy – FDA Inspection, Aug 1, 2017
Record Details
This FDA Inspection record concerns Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy, with an inspection on August 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 1, 2017
- Product Type
- Drugs
- People
- Gerard P. De Leon (Issuing Officer)
- Kenneth O. Gee (FDA Associated Person)
View Company Profile
ID · 068282b3-70f2-4c37-a766-b0d9a20918ad
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1020745
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.